Patents by Inventor Yasuhiko Kano

Yasuhiko Kano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antitumor agent
    Patent number: 8822422
    Abstract: An antitumor agent containing, in combination, at least one kind of antitumor agent selected from the group consisting of an antitumor agent that forms a cross-link with DNA and shows an antitumor effect, an antimetabolite antitumor agent and a taxane antitumor agent, and a histone deacetylase inhibitor. According to the present invention, an antitumor agent causing reduced side effects and having a superior antitumor activity can be provided.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: September 2, 2014
    Assignee: Astellas Pharma Inc.
    Inventors: Yoshinori Naoe, Takeshi Inoue, Yasuhiko Kano
  • ANTITUMOR AGENT
    Publication number: 20110160295
    Abstract: An antitumor agent containing, in combination, at least one kind of antitumor agent selected from the group consisting of an antitumor agent that forms a cross-link with DNA and shows an antitumor effect, an antimetabolite antitumor agent and a taxane antitumor agent, and a histone deacetylase inhibitor. According to the present invention, an antitumor agent causing reduced side effects and having a superior antitumor activity can be provided.
    Type: Application
    Filed: March 11, 2011
    Publication date: June 30, 2011
    Applicant: Astellas Pharma Inc.
    Inventors: Yoshinori Naoe, Takeshi Inoue, Yasuhiko Kano
  • Antitumor agent
    Patent number: 7951780
    Abstract: An antitumor agent containing, in combination, at least one kind of antitumor agent selected from the group consisting of an antitumor agent that forms a cross-link with DNA and shows an antitumor effect, an antimetabolite antitumor agent and a taxane antitumor agent, and a histone deacetylase inhibitor. According to the present invention, an antitumor agent causing reduced side effects and having a superior antitumor activity can be provided.
    Type: Grant
    Filed: February 24, 2005
    Date of Patent: May 31, 2011
    Assignee: Astellas Pharma Inc.
    Inventors: Yoshinori Naoe, Takeshi Inoue, Yasuhiko Kano
  • Antitumor agent
    Publication number: 20050187149
    Abstract: An antitumor agent containing, in combination, at least one kind of antitumor agent selected from the group consisting of an antitumor agent that forms a cross-link with DNA and shows an antitumor effect, an antimetabolite antitumor agent and a taxane antitumor agent, and a histone deacetylase inhibitor. According to the present invention, an antitumor agent causing reduced side effects and having a superior antitumor activity can be provided.
    Type: Application
    Filed: February 24, 2005
    Publication date: August 25, 2005
    Inventors: Yoshinori Naoe, Takeshi Inoue, Yasuhiko Kano
  • Antitumor agent
    Publication number: 20050187148
    Abstract: An antitumor agent containing, in combination, at least one kind of antitumor agent selected from the group consisting of an antitumor agent that forms a cross-link with DNA and shows an antitumor effect, an antimetabolite antitumor agent and a taxane antitumor agent, and a histone deacetylase inhibitor. According to the present invention, an antitumor agent causing reduced side effects and having a superior antitumor activity can be provided.
    Type: Application
    Filed: April 29, 2004
    Publication date: August 25, 2005
    Inventors: Yoshinori Naoe, Takeshi Inoue, Yasuhiko Kano